GLP3-Reta+ Cagrilintide

This research combination contains retatrutide, a GLP3-R GLP1/GIP/Glucagon receptor multi-agonist, and cagrilintide, an amylin-receptor agonist analogue. Research focuses on receptor pharmacology and downstream signaling in controlled experimental systems. For laboratory research and analytical use only. Not intended for human or veterinary use, diagnosis, treatment, prevention, mitigation, or cure of any disease. No therapeutic or performance claims are made. Researchers are responsible for appropriate handling, institutional review, and compliance with all applicable laws and regulations.